Israel-based Sharon Laboratories invested in the special ingredients manufacturer Res Pharma Industriale

Fineurop Soditic acted as exclusive financial advisor to Sharon Laboratories Ltd in the acquisition of specialty ingredients producer Res Pharma Industriale (RPI).

Company
Res Pharma Industriale
Transaction
Sector
Activity
personal care ingredients
Date
Country
Italia

Established in 2004, RPI is a chemical company specialized in research, innovation and the production of personal care ingredients. RPI has a global customer base for green functional ingredients, such as texturizers, emulsifiers, surfactants and solubilizers – as well as smart solutions for specific segments such as wet wipes. These ingredients are used in virtually every segment of the personal care industry, including cosmetics, haircare, skincare, sun care and more.

A green philosophy drives each innovation choice and strategy regarding both product development (Ecocert, Cosmos, Nature approved products) and a commitment to sustainability (RSPO Member).

Established in 1977 and headquartered in Ashdod (Israel), Sharon Laboratories is a leading global innovator and manufacturer of preservative solutions for cosmetics and personal care markets.

Sharon Laboratories employs more than 100 people worldwide, focusing on scientific research, development and marketing of advanced preservative solutions.

Sharon Laboratories has a global presence and it is a portfolio company of Tene Investment Funds (Tel Aviv), an Israeli private equity growth fund focused on the industrial and technology sectors.

This acquisition allows Sharon Laboratories to expand and diversify its portfolio of cosmetic ingredients and will create a global leader in personal care solutions, especially wet wipes.